Harrow Health (HROW) Financials: Revenue & Earnings

HROW price $29.34 +0.28 +0.95%

Ticker
HROW
Price
$29.34
Change
+0.28 +0.95%
Market cap ?
$1.10B
P/E ?
-28.65
Forward P/E ?
13.46
Dividend yield ?
0.00%
Beta ?
0.24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
58
Value
42
Quality
39
Growth
93

Stocklytics score rationale: value 42, quality 39, growth 93.

Financials

2016201720182019202020212022202320242025
19942000267740004137200051165000488710007247600088595000130193000199614000272303000

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical…

Fair value

HROW fair value $97.14. Price $29.34. Price is 70% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 70.59M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 37.49M. Net debt 179.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare HROW

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—0.17—98.47M
2026-08-10-0.46-0.1870.66M70.35M
2026-05-11-0.74-0.4344.20M52.43M
2026-03-020.180.4089.09M90.00M
2025-11-100.030.2271.64M73.70M
2025-08-110.140.0163.74M66.00M
2025-05-08-0.500.0247.83M57.00M
2025-03-270.240.0866.83M61.79M
2024-11-13-0.12-0.0549.26M52.80M
2024-08-07-0.18-0.2548.90M42.51M
2024-05-13-0.38-0.2534.59M36.32M
2024-03-20-0.25-0.0436.35M37.86M
2023-11-13-0.090.0334.30M37.58M
2023-08-09-0.14-0.0433.47M31.04M
2023-05-11-0.22-0.0626.10M25.13M
2023-03-230.07-0.1520.33M21.40M
2022-11-14-0.240.0222.82M23.14M
2022-08-09-0.23-0.0223.32M22.07M
2022-05-05-0.09-0.0422.12M19.48M
2022-03-10-0.27-0.0420.19M19.35M
2021-11-090.050.0318.71M15.44M
2021-08-10-0.09-0.0318.13M15.71M
2021-05-110.01-0.0415.44M13.66M
2021-03-080.040.0414.60M14.45M
2020-11-090.330.1714.40M77.75M
2020-08-10-0.01-0.108.06M80.60M
2020-05-11-0.50-0.2511.82M5.91M
2020-03-130.100.0612.60M7.56M
2019-11-13-0.45-0.4412.76M8.88M
2019-08-14-0.09-0.0813.52M12.01M
2019-05-090.430.1212.29M285.81K
2019-03-120.770.3411.38M5.03M
2018-11-13-0.12—10.74M—
2018-08-060.11—10.38M—
2018-05-15-0.17—8.87M—
2018-03-08-0.13—7.34M—
2017-11-14-0.28—6.48M—
2017-08-100.07—6.86M—
2017-05-10-0.26-0.196.10M4.46M
2017-03-21-0.30-0.285.79M5.40M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-14Shojaei AmirSell11.25K$35.96404.55K
2026-08-14Shojaei AmirBuy11.25K$35.96404.55K
2026-08-14Shojaei AmirSell11.25K$40.00450.00K
2026-06-18Sternberg Perry J.Buy5.25K——
2026-06-18SILVERNAIL LAUREN PBuy5.25K——
2026-06-18Graves Adrienne LBuy5.25K——
2026-05-18Graves Adrienne LBuy1.00K$31.0731.07K
2026-05-18SILVERNAIL LAUREN PBuy1.00K$31.0031.00K
2026-05-15Shojaei AmirBuy10.00K——
2026-05-14BAUM MARK LBuy10.00K$30.20302.00K
2026-05-14BOLL ANDREW R.Buy3.50K$29.90104.65K
2026-03-04Opaleye Management Inc.Sell134.00K$39.675.32M
2026-03-04Opaleye Management Inc.Sell4.26K$39.67169.12K
2026-03-03Opaleye Management Inc.Sell59.00K$39.152.31M
2026-03-03Opaleye Management Inc.Sell1.31K$39.1551.25K
2026-02-27Opaleye Management Inc.Sell5.00K$54.18270.90K
2026-01-30Sullivan Patrick WilliamBuy25.00K——
2026-01-30Sullivan Patrick WilliamBuy15.00K——
2026-01-30Sullivan Patrick WilliamOther30.00K$39.001.17M
2026-01-06Opaleye Management Inc.Sell20.00K$53.351.07M
2025-12-12BOLL ANDREW R.Buy60.00K$3.95237.00K
2025-12-12BOLL ANDREW R.Sell26.66K$47.061.25M
2025-12-12BOLL ANDREW R.Sell60.00K$3.95237.00K
2025-12-12BAUM MARK LBuy180.00K$3.95711.00K
2025-12-12BAUM MARK LSell79.99K$47.063.76M
2025-12-12BAUM MARK LSell180.00K$3.95711.00K
2025-10-06Mullery Francis William JrOther33.00K$48.181.59M
2025-09-01Pollard Randall E.Buy30.00K$39.001.17M
2025-09-01Pollard Randall E.Other0——
2025-07-21BAUM MARK LBuy600.00K$7.874.72M
2025-07-21BAUM MARK LSell313.34K$37.0811.62M
2025-07-01BOLL ANDREW R.Buy405.75K——
2025-07-01BAUM MARK LBuy889.50K——
2025-06-20Sternberg Perry J.Buy7.34K——
2025-06-20SILVERNAIL LAUREN PBuy7.34K——
2025-06-20Graves Adrienne LBuy7.34K——
2025-06-10Opaleye Management Inc.Sell15.00K$30.80462.03K
2025-06-09Opaleye Management Inc.Sell15.20K$30.37461.79K
2025-06-04Opaleye Management Inc.Sell1.80K$30.0253.91K
2025-06-03Opaleye Management Inc.Sell3.00K$30.0490.12K
2025-05-13Opaleye Management Inc.Sell5.00K$26.59132.94K
2025-05-12Opaleye Management Inc.Sell10.00K$25.90258.96K
2025-04-07BOLL ANDREW R.Sell136.75K$23.093.16M
2025-04-07SAHAREK JOHN P.Sell109.47K$23.092.53M
2025-04-07BAUM MARK LSell300.36K$23.096.94M
2025-04-03BOLL ANDREW R.Buy346.50K——
2025-04-03BOLL ANDREW R.Sell346.50K——
2025-04-03SAHAREK JOHN P.Buy277.20K——
2025-04-03SAHAREK JOHN P.Sell277.20K——
2025-04-03BAUM MARK LBuy762.30K——
2025-04-03BAUM MARK LSell762.30K——
2025-03-24Opaleye Management Inc.Sell5.00K$30.01150.06K
2025-03-18Opaleye Management Inc.Sell5.00K$30.01150.06K
2025-03-18Opaleye Management Inc.Sell5.00K$29.64148.20K
2025-02-28Opaleye Management Inc.Sell5.00K$28.05140.25K
2025-01-22Opaleye Management Inc.Sell20.00K$35.59711.81K
2025-01-06Shojaei AmirBuy30.00K$35.961.08M
2025-01-06Shojaei AmirOther0——
2024-09-11SAHAREK JOHN P.Buy90.00K$7.37663.30K
2024-09-11SAHAREK JOHN P.Sell45.14K$41.371.87M
2024-09-11SAHAREK JOHN P.Sell90.00K$7.37663.30K
2024-06-14Sternberg Perry J.Buy8.35K——
2024-06-14Makary Martin A.Buy8.35K——
2024-06-14Graves Adrienne LBuy8.35K——
2024-06-14SILVERNAIL LAUREN PBuy8.35K——
2024-04-25Opaleye Management Inc.Buy20.00K$9.97199.40K
2024-04-24Opaleye Management Inc.Buy8.29K$10.1584.09K
2024-04-23Opaleye Management Inc.Buy11.71K$10.29120.55K
2024-04-19Opaleye Management Inc.Buy29.40K$10.56310.39K
2024-03-28Opaleye Management Inc.Buy50.00K$12.82641.00K
2024-03-22BAUM MARK LBuy9.00K$11.59104.31K
2024-03-20Opaleye Management Inc.Buy50.60K$9.65488.29K
2024-03-01SAHAREK JOHN P.Buy5.00K$8.7543.75K
2024-03-01SAHAREK JOHN P.Sell5.00K$8.7543.75K
2024-02-20SAHAREK JOHN P.Buy30.00K$10.67320.10K
2024-02-20SAHAREK JOHN P.Sell12.62K$10.67134.61K
2024-02-20SAHAREK JOHN P.Sell30.00K——
2024-02-20BOLL ANDREW R.Buy45.00K$10.67480.15K
2024-02-20BOLL ANDREW R.Sell18.48K$10.67197.18K
2024-02-20BOLL ANDREW R.Sell45.00K——
2024-02-20BAUM MARK LBuy150.00K$10.671.60M
2024-02-20BAUM MARK LSell59.84K$10.67638.45K
2024-02-20BAUM MARK LSell150.00K——
2024-02-07BAUM MARK LBuy15.40K$7.71118.73K
2024-02-07BAUM MARK LSell15.40K$7.71118.73K
2024-02-07BOLL ANDREW R.Buy7.40K$7.7157.05K
2024-02-07BOLL ANDREW R.Sell7.40K$7.7157.05K
2024-01-26Graves Adrienne LBuy3.12K——
2024-01-26SILVERNAIL LAUREN PBuy3.12K——
2024-01-26SILVERNAIL LAUREN POther0——
2024-01-26Graves Adrienne LOther0——
2023-11-16BAUM MARK LBuy7.50K$8.1160.82K
2023-11-15Opaleye Management Inc.Buy25.00K$8.03200.74K
2023-11-10SAHAREK JOHN P.Buy20.00K——
2023-11-10SAHAREK JOHN P.Sell9.78K$12.83125.45K
2023-11-10SAHAREK JOHN P.Sell20.00K$4.1683.20K
2023-09-20Opaleye Management Inc.Buy5.98K$14.4986.71K
2023-09-19Opaleye Management Inc.Buy14.02K$14.65205.37K
2023-08-14BAUM MARK LBuy5.80K$17.0598.89K
2023-08-14Makary Martin A.Buy20.00K$16.92338.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 234, holders +7 vs prior quarter. Ownership 58.49%.

HolderSharesChangeChange %Value
BLACKROCK, INC.2.74M187.36K+7.34%116.37M
OPALEYE MANAGEMENT INC.2.40M-432.23K-15.26%101.93M
PRIVATE CAPITAL MANAGEMENT, LLC1.60M1.56M+3799.44%67.90M
VANGUARD CAPITAL MANAGEMENT LLC1.42M14.16K+1.01%60.19M
DEEP TRACK CAPITAL, LP969.00K969.00KNew41.15M
STATE STREET CORP939.89K84.84K+9.92%39.92M
GEODE CAPITAL MANAGEMENT, LLC905.56K53.53K+6.28%38.47M
BAMCO INC /NY/809.35K809.35KNew34.37M
SUSQUEHANNA INTERNATIONAL GROUP, LLP742.90K434.60K+140.97%31.55M
DIMENSIONAL FUND ADVISORS LP667.04K87.52K+15.10%28.33M
JUPITER TOPCO LLC579.13K579.13KNew24.60M
DIVISADERO STREET CAPITAL MANAGEMENT, LP439.15K439.15KNew18.65M
CITADEL ADVISORS LLC391.40K221.30K+130.10%16.62M
RICE HALL JAMES & ASSOCIATES, LLC387.55K19.37K+5.26%16.46M
MARSHALL WACE, LLP369.44K-275.48K-42.72%15.69M
CITADEL ADVISORS LLC359.87K189.77K+111.57%15.28M
NORTHERN TRUST CORP323.21K26.34K+8.87%13.73M
SCHONFELD STRATEGIC ADVISORS LLC319.62K319.62KNew13.57M
VANGUARD PORTFOLIO MANAGEMENT LLC318.61K29.73K+10.29%13.53M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC273.70K3.16K+1.17%11.62M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.273.70K273.70KNew11.62M
VANGUARD FIDUCIARY TRUST CO235.42K7.80K+3.43%10.00M
CITADEL ADVISORS LLC233.00K62.90K+36.98%9.90M
WESTSIDE INVESTMENT MANAGEMENT, INC.224.05K38.12K+20.51%9.52M
FIRSTWAVE CAPITAL MANAGEMENT LLC211.98K68.06K+47.29%9.00M

Earnings and financials

Harrow Health, Inc. (HROW) trades at $29.34, with a market cap of $1.10B and a trailing P/E of -28.65. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
19942000267740004137200051165000488710007247600088595000130193000199614000272303000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Harrow Health (HROW) Financials: Revenue & Earnings

HROW$29.34+0.28 +0.95%

$1.10B

Market Cap

-28.65

P/E

13.46

Forward P/E

58

Score

Price History